Loading
Californian maker of tissue-typing tests, a Thermo Fisher Scientific subsidiary, whose HLA sequencing system is the FDA companion diagnostic for tebentafusp and afamitresgene autoleucel.
One Lambda, Inc., the applicant at West Hills, California on the FDA record for its SeCore CDx HLA Sequencing System (BK241074, 1 August 2024), makes HLA typing products. The FDA companion diagnostic list names it as maker of SeCore CDx HLA for tebentafusp in uveal melanoma and for afamitresgene autoleucel in synovial sarcoma. Thermo Fisher Scientific lists One Lambda, Inc, a California company, among its subsidiaries in the exhibit to its annual report for 2025.
The blood test that checks a person's tissue type (HLA-A*02) before tebentafusp for uveal melanoma or afamitresgene autoleucel for synovial sarcoma.
Shares SeCore CDx HLA Sequencing System, Synovial sarcoma, Companion diagnostics.
Shares SeCore CDx HLA Sequencing System, Synovial sarcoma, Uveal melanoma.
Shares SeCore CDx HLA Sequencing System, Synovial sarcoma, Uveal melanoma.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/